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Background: The POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Mono-
clonal immunoglobulin, Skin changes) syndrome is a rare disease that entails a
specific risk for pulmonary arterial hypertension.
Methods and results: We report on 2 patients who suffered from POEMS syndrome
and pulmonary arterial hypertension for whom a detailed hemodynamic pul-
monary study was obtained before and after steroid treatment. Patient 1 had
defined post-capillary pulmonary hypertension (PH) ascribed to an abnormally
high cardiac output. Patient 2 suffered from severe pre-capillary PH. Under
high-dose steroids treatment, clinical symptoms disappeared and PH assessment
by sequential hemodynamic study showed a clear-cut improvement in both
patients.
Conclusion: First-line therapy should include corticosteroids in POEMS syndrome-
related PH.
& 2006 Published by Elsevier Ltd.Introduction
The POEMS (Polyneuropathy, Organomegaly, Endo-
crinopathy, Monoclonal immunoglobulin, SkinPublished by Elsevier Ltd.
0 25 70 00,
aphp.fr (T. Papo).changes) syndrome is a rare form of plasma cell
dyscrasia, characterized by the association of
Polyneuropathy, Organomegaly, Endocrinopathy,
Monoclonal immunoglobulin and Skin changes.
Renal failure, thrombotic events, capillary-leak
syndrome with papilledema, congestive heart fail-
ure and pulmonary hypertension (PH) may also
occur.1
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syndrome and PH documented by sequential cardi-
ac catheterization.Case reports
Patient 1
A 50-year-old woman presented in June 1998 with
sensorimotor demyelinating polyneuropathy and
increased CSF protein content; the association to
organomegaly—including adenopathy, hepatome-
galy and splenomegaly , hypothyroidy , serum IgA l
monoclonal immunoglobulin, numerous osteoclero-
tic lesions, hemangiomas and Raynaud phenomenon
led to the diagnosis of POEMS syndrome. Oral
prednisone was started at 1mg kg1 d1. Clinical
status improved. She was again admitted in June
2002 for exertional dyspnea, anasarca and papille-
dema. At this time, prednisone dosage was
8mgd1. PH was confirmed by right heart cathe-
terization: mean pulmonary artery pressure
(35mmHg), cardiac index (4.98 Lmin1m2), and
pulmonary capillary wedge pressure (16mmHg)
were elevated, whereas pulmonary vascular resis-
tance (164 dyn s cm5) was normal. Post-capillary
PH was interpreted as secondary to high-output
cardiac failure, in the context of splenomegaly and
specific capillary leak syndrome. Prednisone dosage
was increased to 1mg kg1 d1. Rapid and complete
regression of respiratory discomfort and edema,
and partial improvement of neurologic manifesta-
tions were noted. Seven months later, dyspnea,
orthopnea and edema had disappeared, and hemo-
dynamic control confirmed normalization of mean
pulmonary artery pressure at 25mmHg, pulmonary
capillary wedge pressure at 10mmHg, pulmonary
vascular resistance 126 dyn s cm5, and persistent
high cardiac index 4.88 Lmin1m2.
Patient 2
A 56-year-old man was admitted in April 1998 for
peripheral edema, dyspnea (NYHA III), and refrac-
tory ascites. The patient had a history of severe
venous thromboembolic disease starting in 1996.
Post-embolic precapillary PH was defined by ele-
vated mean pulmonary artery pressure 46mmHg,
and pulmonary vascular resistance at
530 dyn s cm5, and decreased venous oxygen sa-
turation 62%. He was treated with pulmonary
thromboendarteriectomy in March 1997 which
allowed decrease of mean pulmonary artery pres-
sure to 36mmHg, and of pulmonary vascularresistance to 314 dyn s cm5, venous oxygen satura-
tion 67%. Eight months later, in November 1997,
hemodynamic parameters had deteriorated with
increased mean pulmonary artery pressure to
42mmHg, increased pulmonary vascular resistance
to 386 dyn s cm5, and decreased venous oxygen
saturation 57%, without new thromboembolic event
disclosable by angiography. At this time a refrac-
tory protein-rich ascites needed weekly paracent-
esis. Liver biopsy specimen was normal. The
presence of demyelinating polyneuropathy, hepa-
tomegaly and splenomegaly, endocrine dysfunc-
tions (hypothyroidy, gynecomastia), hemangiomas,
monoclonal IgA l, Raynaud phenomenon, skin
sclerosis and white nails led to the diagnosis of
POEMS syndrome with precapillary PH. Accordingly,
high-dose steroid treatment was started. After 1
month of prednisone 1mg kg1 d1, dyspnea, ede-
ma and ascites had disappeared, whereas pulmon-
ary arterial pressure (28mmHg) and venous oxygen
saturation (74%) had normalized, and pulmonary
vascular resistance decreased to 259 dyn s cm5.Discussion
Twenty-two cases—including ours—of PH compli-
cating POEMS syndrome have been reported so
far.1–9 A rough 5% prevalence may be deduced from
the largest published series, where 5 patients out
of 99 POEMS cases had PH.1 Seven—including
patient 2 out of 10 patients who underwent
hemodynamic study had precapillary PH.
Three—including patient 1—had hemodynamic
characteristics of postcapillary PH with elevated
cardiac index.7
Twelve patients were treated with corticoster-
oids.4–9 Only 3 patients—including our 2 cases
—underwent a second heart catheterization for
steroid treatment evaluation.8 In these 3 cases,
mean pulmonary artery pressure and pulmonary
vascular resistance normalized or significantly
decreased in 3–7 months.
Mechanisms of PH in POEMS syndrome remain
unclear. In patient 1, post-capillary PH was caused
by high-output heart failure. The role of splenic
enlargement with parallel increase of splenic blood
flow is probable.10 In other patients, as in patient
2, a primary arterial process with cytokine
mediated-vascular inflammation seems responsible
for PH. Lung specimen analysis shows plexogenic
pulmonary vasculopathy mimicking primary PH.5
Various types of venous and arterial thromboem-
bolic events may also occur, predisposing to post-
embolic PH, as in patient 2.1
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shown to affect patients with primary PH. Multi-
centric Castleman’s disease, which is associated with
HHV8, is also a feature of POEMS syndrome although
HHV8 has been implicated in the POEMS syndrome
with conflicting results.11 Interestingly, reversible
pulmonary hypertension has been described in HIV/
HHV8-associated Castleman’s disease.12
In conclusion, since it may induce durable
pulmonary arterial hypertension improvement in
the setting of POEMS syndrome, steroid treatment
should be used as first line therapy.References
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